Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitis B Patient

NCT03294798 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B Virus

Interventions

BIOLOGICAL: Human Serum Albumin/interferon alpha2b fusion protein
BIOLOGICAL: Pegasys

Sponsor

Tianjin SinoBiotech Ltd.